$BPTH skyrockets on Received Third U.S. Patent Grant
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。